Organization Overview
Alternative names
anastrozole (arimidex) (1 trial)
atezolizumab (Tecentriq) (2 trials)
bevacizumab (avastin) (6 trials)
carboplatin (paraplatin) (7 trials)
docetaxel (taxotere) (1 trial)
dostarlimab (Jemperli) (2 trials)
doxorubicin (Doxil) (2 trials)
durvalumab (imfinzi) (4 trials)
gemcitabine (gemzar) (1 trial)
Carcinoma, Ovarian Epithelial (Phase 3)
Endometrial Neoplasms (Phase 3)
Fallopian Tube Neoplasms (Phase 3)
Hypersensitivity (Phase 3)
Ovarian Neoplasms (Phase 3)
Peritoneal Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 2)